Augmented type 1 cytokines and human endogenous retroviruses specific immune responses in patients with acute multiple sclerosis

Journal of NeuroVirology

Volumn 6, Issue SUPPL. 2, 2000, Pages

  Trabattoni, Daria ^a   Ferrante, Pasquale ^a   Fusi, Maria Luisa ^a   Saresella, Marina ^b   Caputo, Domenico ^b   Urnovitz, Howard ^c   Cazzullo, Carlo Luigi ^d   Clerici, Mario ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

^c Calypte Biomedical Corporation   (United States)

^d AGRICULTURAL RESEARCH SERVICE   (United States)

Author keywords

Cytokines; HERV; Multiple sclerosis

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2; MITOGENIC AGENT;

ADULT; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOLOGY; MALE; MULTIPLE SCLEROSIS; NORMAL HUMAN; PRIORITY JOURNAL; RETROVIRUS;

ACUTE DISEASE; ADULT; ANTIGENS, VIRAL; CHRONIC DISEASE; CYTOKINES; ENDOGENOUS RETROVIRUSES; FEMALE; HUMANS; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-2; MALE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; TUMOR NECROSIS FACTOR-ALPHA;

HUMAN ENDOGENOUS RETROVIRUSES; UNIDENTIFIED RETROVIRUS;

EID: 0034040489     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (27)

1. Benveniste EN (1997). Role of macrophages/microglia in multiple sclerosis and experimental allergic encephalomyelitis. J Mol Med 75: 165-173.
2. Cianciolo GJ, Copeland TD, Oroszlan S, Snyderman R (1985). Inhibition of lymphocyte proliferation by a synthetic peptide homologous to retroviral envelope proteins. Science 223: 364-370.
3. Clerici M, Giorgi JV, Chou CC, Gudeman VK, Zack JA, Gupta P, Ho H-N, Nishanian PG, Berzofsky JA, Shearer GM (1992). Cell mediated immune response to human immunodeficiency virus type 1 (HIV-1) in seronegative homosexuals with recent sexual exposure to HIV-1. J Infect Dis 165: 1012-1019.
4. Dalgleish AG (1987). Viruses and multiple sclerosis. Acta Neurol Scand S169: 8-15.
5. Gebickehaerter PJ, Vancalker D, Norenberg W, Illes P (1996). Molecular mechanisms of microglial activation a implications for regeneration and neurodegenerative diseases. Neurochem Int 29: 1-12.
6. Haraguchi S, Good RA, Day NK (1995). Immunosuppressive retroviral peptides: cAMP and cytokine patterns. Immunol Today 16: 595-601.
7. Heinzel FP, Hujer AM, Ahmed FN, Rerko RM (1997). In vivo production of IL12 p40 homodimers. J Immunol 158: 4381.
8. Hohlfeld R, Lucas K (1994). Cytokines networks in multiple sclerosis. Neurology 45 (suppl 6): S1.
9. Kato K, Shimozato O, Hoshi K, Wakimoto H, Hamada H, Yagita H, Okumura K (1996). Local production of the p40 subunit of IL12 suppresses T Helper 1-mediated immune responses and prevents allogeneic myoblast rejection. J Immunol 156: 9085.
10. Krieg AM, Gourley MF, Perl A (1992). Endegenous retroviruses: potential etiologic agents in autoimmunity. FASEB J 6: 2537-2544.
11. Kurtzke JF (1987). Epidemiological evidence for multiple sclerosis as an infection. Clin Microbiol Rev 6: 382-427.
12. Li H, Cuzner ML, Newcombe J (1996). Microglia-derived macrophages in early multiple sclerosis plaques. Neuropathol Applied Neurobiol 22: 207-215.
13. Martin R, McFarland HF (1995). Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis. Crit Rev Clin Lab Sci 32: 121-128.
14. Murray PD, Mcgavern DB, Lin XQ, Njenga MK, Leibowitz J, Pease LR, Rodriguez M (1998). Perforin-dependent neurologic injury in a viral model of multiple sclerosis. J Neurosci 18: 7306-7314.
15. Nakagawa K, Harrison LC (1997). The potential roles of endogenous retroviruses in autoimmunity. Immunol Rev 152: 193-236.
16. Navikas V, He B, Link J, Haglund M, Sodderstrom M, Fredrickson S, Link H (1996). Augmented expression of tumor necrosis and lymphotoxin in mononuclear cells in multiple sclerosis and optic neuritis. Brain 119: 213.
17. Nelson M, Nelson DS, Cianciolo GJ, Snyderman R (1989). Effect of CKS-17, a synthetic retroviral envelop peptide, on cell-mediated immunity in vivo: immunosuppression, immunogenicity, and relation to immunosuppressive tumor products. Cancer Immunol Immunother: 30: 113-118.
18. Olsson T, Wang WZ, Hojeberg B, Link J (1990). Autoreactive T lymphocytes in multiple sclerosis determined by antigen-induced secretion of interferon gamma. J Clin Invest 86: 981.
19. Oostendorp RA, Meijer Q, Scheper RJ (1993). Immunosuppression by retroviral-envelope-related proteins, and their role in non-retroviral human disease. Crit Rev Onc-Hematol 14: 189-206.
20. Poser CM (1993). The pathogenesis of multiple sclerosis. Additional consideration. J Neurol Sci 115 (suppl), S3-S8.
21. Rasmussen HB, Perron H, Clausen J (1993). Do endogenous retroviruses have etiologic implications in inflammatory and degenerative nervous system diseases? Acta Neurol Scand 88: 190-198.
22. Rieckmann P, Albrecht M, Kitze B (1994). Cytokine mRNA levels in mononuclear blood cells from patients with multiple sclerosis. Neurology 44: 1523-1529.
23. Rudge P (1991). Does a retrovirally encoded superantigen cause multiple sclerosis? J Neurol Neurosurg Psychiatry 54: 853-855.
24. Sriram S, Rodriguez M (1997). Indictment of the microgleia as the villain in multiple sclerosis. Neurol 48: 464-470.
25. Steinman L (1996). Multiple Sclerosis: a coordinated immunological attack against myelin in the central nervous system. Cell 85: 299-302.
26. Urnovitz HB (1996). Urine-based diagnostic technologies. Trends Biotechnol 152: 361-364.
27. Wucherpfenning K, Strominger JL (1995). Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell 80: 695-700.